Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@longevitytech.bsky.socialOct 9, 2026, 10:18 AM

First-in-human ER-100 data support dose escalation, with early visual-field signals in two of three glaucoma patients.

Link as first comment.

#longevity #geroscience #ER100 #glaucoma #clinicaldata

Close-up of an elderly person's eye with text about cellular rejuvenation.
@fiosgenomics.bsky.socialOct 7, 2026, 3:30 PM

Make clinical data mining easier for yourself!
Learn how to overcome the most common challenges, by reading our blog:

https://www.fiosgenomics.com/challenges-in-clinical-data-mining/

#clinicaldata #datamining #drugdevelopment #bioinformatics

@onc-rg.bsky.socialOct 2, 2026, 12:07 AM

π™π™π™š 2026 π™€π™Žπ™ˆπ™Š π™‡π˜½π˜Ό π™‡π™–π™£π™™π™¨π™˜π™–π™₯π™š: π™‘π™žπ™¨π™ͺπ™–π™‘π™žπ™―π™šπ™™.
Which mechanisms are commanding the late-breaker spotlight this year?

#ESMO2026 #ESMO26 #Oncology #NSCLC #SCLC #ADCs #vaccines #ClinicalData #DrugTrials #CompetitiveStrategy

Our analysts crunched the numbers across all LBAs:
βœ”οΈADCs lead the field β€” nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond
βœ”οΈCheckpoint inhibition isn't just a category β€” it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more
βœ”οΈBeyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO

Stay ahead of the competitive curve with verified insights.
Our analysts crunched the numbers across all LBAs:
βœ”οΈADCs lead the field β€” nearly a third of all LBA drugs, spanning NSCLC, breast, ovarian, and beyond
βœ”οΈCheckpoint inhibition isn't just a category β€” it's still the default combo partner, showing up alongside ADCs, vaccines, PARP inhibitors and more
βœ”οΈBeyond PD-(L)1 and the usual ADC targets (HER2, TROP-2, B7-H3), RAS/KRAS momentum is continuing from ASCO

Stay ahead of the competitive curve with verified insights.
@biorasi.bsky.socialSep 21, 2026, 1:23 PM

πŸ“£A big shoutout to #SCDM for another outstanding event!

Thank you to everyone who stopped by to connect with us. We look forward to seeing you again next year in Atlanta.

#Biorasi2026 #BiorasiHive #datasciences #CRO #clinicaldata

@fiosgenomics.bsky.socialSep 16, 2026, 3:30 PM

πŸ”¬ Linear Mixed Effects Models
Repeated measures in clinical trials= correlated data points.
Are you using the right model?
Learn how linear mixed effects models help analyse repeated measures data:
https://www.fiosgenomics.com/linear-mixed-effects-models
#bioinformatics #clinicaldata #datascience